Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States

Background: In September 2014, 13-valent pneumococcal conjugate vaccine (PCV13) was universally recommended for all US adults aged ≥65 years. Adult PCV13 coverage, including whether disparities in uptake exist, however, is not well-described. Methods: We used a monthly series of cross-sectional anal...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, John M., Swerdlow, David L., Khan, Farid, Will, Oliver, Curry, Aaron, Snow, Vincenza, Isturiz, Raul E., Jodar, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605819/
https://www.ncbi.nlm.nih.gov/pubmed/30676236
http://dx.doi.org/10.1080/21645515.2018.1564434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605819/
https://www.ncbi.nlm.nih.gov/pubmed/30676236
http://dx.doi.org/10.1080/21645515.2018.1564434

Ejemplares similares